Ensysce Biosciences to Host Virtual Investor Day on July 27, 2021
July 21, 2021 08:00 ET
|
Ensysce Biosciences Inc.
SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical stage biotech company with proprietary technology platforms...
Ensysce Biosciences Receives Notice of Award for Year Three of Multi-Year NIDA Grant for the Clinical Development of its Next Generation Opioid Products with Overdose Protection
July 08, 2021 08:00 ET
|
Ensysce Biosciences Inc.
SAN DIEGO, July 08, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (NASDAQ: ENSC) (“Ensysce” or “the Company”), a clinical stage biotech company with proprietary technology platforms to reduce...
Ensysce Biosciences to Begin Trading its Common Stock on The Nasdaq Capital Market on July 2, 2021
July 01, 2021 16:39 ET
|
Ensysce Biosciences Inc.
SAN DIEGO, July 01, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW) today announced that the Company will begin trading its common stock...
Ensysce Biosciences to Commence Trading on the OTC on July 1, 2021
June 30, 2021 20:32 ET
|
Ensysce Biosciences Inc.
SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (OTC: LACQ, LACQW) today announced that, in connection with the closing of its previously...
Ensysce Biosciences Announces Closing of Merger
June 30, 2021 16:22 ET
|
Ensysce Biosciences Inc.
Ensysce Common Stock to commence trading under ticker symbol “ENSC” on The Nasdaq Capital Market July 1, 2021. Ensysce Warrants will trade on the OTC Markets under the symbol ENSCW.Ensysce is...
Ensysce Biosciences’ Covistat Subsidiary “At Home Coronavirus Pill” Commencing to Phase 2 clinical development
May 07, 2021 08:00 ET
|
Ensysce Biosciences Inc.; Leisure Acquisition Corp
NEW YORK and SAN DIEGO, May 07, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce”), which has entered into an agreement for a business combination with Leisure Acquisition Corp. (“LACQ”)...
Ensysce Biosciences Receives Investigational New Drug Allowance for its Unique PF614-MPAR™ Opioid with Overdose Protection
April 29, 2021 08:00 ET
|
Ensysce Biosciences Inc.; Leisure Acquisition Corp.
NEW YORK and SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce”) and Leisure Acquisition Corp. (“LACQ”) (NASDAQ: LACQ, LACQU, LACQW), a special purpose acquisition...